Yarrow Bioscience Inc Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Yarrow Bioscience Inc (YARW) holds an ST Score of 39.6 out of 100 (C), with its strongest factor being Financial Strength (A+) and its weakest Forecast (D). Analysts rate YARW Buy across 1 ratings with a $5.75 average price target (-0.8% vs the current $29.29).
- Strongest
- Financial StrengthA+
- Weakest
- ForecastD
All factor grades
- Financial StrengthA+
- ValuationC+
- MomentumC
- GrowthC-
- ProfitabilityD
- ForecastD
- Piotroski3/9
Contact
YARW stock: frequently asked questions
What is YARW's ST Score?
Yarrow Bioscience Inc (YARW) has an ST Score of 39.6 out of 100, an overall grade of C. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is YARW a buy, sell, or hold?
Wall Street's consensus rating on YARW is Buy based on 1 analyst ratings. Our own ST Score grades it C (39.6/100). This is data, not investment advice — always do your own research.
What is YARW's valuation grade?
Yarrow Bioscience Inc (YARW) earns a valuation grade of C+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is YARW's growth grade?
Yarrow Bioscience Inc (YARW) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is YARW's profitability grade?
Yarrow Bioscience Inc (YARW) earns a profitability grade of D, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is YARW's financial strength grade?
Yarrow Bioscience Inc (YARW) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for YARW?
The average analyst price target for Yarrow Bioscience Inc (YARW) is $5.75 from 1 analysts, which is -0.8% versus the recent price of $29.29.
What is YARW's Piotroski score?
Yarrow Bioscience Inc (YARW) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.